Ketamine, N,N-dimethyltryptamine (DMT), and other psychoplastogens possess enormous potential as neurotherapeutics due to their ability to potently promote neuronal growth. Here, we report the first-ever structure-activity relationship study with the explicit goal of identifying novel psychoplastogens. We have discovered several key features of the psychoplastogenic pharmacophore and used this information to develop N,N-dimethylaminoisotryptamine (isoDMT) psychoplastogens that are easier to synthesize, have improved physicochemical properties, and possess reduced hallucinogenic potential as compared to their DMT counterparts
A feature of human culture is that we can learn to consume chemical compounds, derived from natural ...
Major depressive disorder (MDD) affects more than 264 million people worldwide. A wide range of anti...
The 5-HT2A receptor is thought to be the primary target for psilocybin (4-phosphoryloxy-N,N-dimethyl...
Neural plasticity-the ability to change and adapt in response to stimuli-is an essential aspect of h...
Neural plasticity—the ability to change and adapt in response to stimuli—is an essential aspect of h...
During the past 13 years we have been working on the biochemistry and pharmacology of the various N-...
The ability of psychedelics to treat a myriad of brain disorders has made them appealing drug target...
Cortical neuron atrophy is a hallmark of depression and includes neurite retraction, dendritic spine...
N,N-dimethyltryptamine (DMT) is a powerful serotonergic psychedelic whose exogenous administration e...
Summary: Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology o...
N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of pla...
In this paper we determined the pharmacological profiles of novel ketamine and phencyclidine analogu...
In this paper we determined the pharmacological profiles of novel ketamine and phencyclidine analogu...
Conformationally rigidified analogs of prototypical hallucinogens were synthesized as probes for the...
N-N dimethyltryptamine (DMT) the tryptamine derivatives have been arousing increased interest. A tea...
A feature of human culture is that we can learn to consume chemical compounds, derived from natural ...
Major depressive disorder (MDD) affects more than 264 million people worldwide. A wide range of anti...
The 5-HT2A receptor is thought to be the primary target for psilocybin (4-phosphoryloxy-N,N-dimethyl...
Neural plasticity-the ability to change and adapt in response to stimuli-is an essential aspect of h...
Neural plasticity—the ability to change and adapt in response to stimuli—is an essential aspect of h...
During the past 13 years we have been working on the biochemistry and pharmacology of the various N-...
The ability of psychedelics to treat a myriad of brain disorders has made them appealing drug target...
Cortical neuron atrophy is a hallmark of depression and includes neurite retraction, dendritic spine...
N,N-dimethyltryptamine (DMT) is a powerful serotonergic psychedelic whose exogenous administration e...
Summary: Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology o...
N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of pla...
In this paper we determined the pharmacological profiles of novel ketamine and phencyclidine analogu...
In this paper we determined the pharmacological profiles of novel ketamine and phencyclidine analogu...
Conformationally rigidified analogs of prototypical hallucinogens were synthesized as probes for the...
N-N dimethyltryptamine (DMT) the tryptamine derivatives have been arousing increased interest. A tea...
A feature of human culture is that we can learn to consume chemical compounds, derived from natural ...
Major depressive disorder (MDD) affects more than 264 million people worldwide. A wide range of anti...
The 5-HT2A receptor is thought to be the primary target for psilocybin (4-phosphoryloxy-N,N-dimethyl...